Alkermes
Biotechnology Research • 
Dublin, Co Dublin, Ireland • 2001-5000 Employees
Company overview
| Headquarters | Dublin, Co Dublin, Ireland |
| Phone number | +3536358950 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Sales, Medical Affairs, Pharmaceutical, Pharma, Addiction, Marketing, Manufacturing, Research & Development, R&D, Human Resources, IT, Biotech, Information Technology, Addiction, Neuroscience, CNS, Narcolepsy, Sleep Disorders, Serious Mental Illness, District Sales, Regional Sales |
| Founded | 1987 |
| Employees | 2001-5000 |
| Socials |
Key Contacts at Alkermes
Daniel Bergmann
Associate Director, Hr Business Partner
Than Taylor
Director, Talent Acquisition – Commercial And Ta Systems
Joelle Smith
Associate Director Of Market Development East
Pete Mello
Executive Director, Talent Aquisition
Diana Hudson
Associate Director, Regional Accounts
Reena Malik
Associate Director Regulatory Affairs
Glenn Cornish
Senior Director Government Accounts
Leila Nosrat
Director, Corporate Counsel, R&D
Michael Hale
Senior Director, Manufacturing Operations
Susan Colby
Director, Human Resources
Alkermes Email Formats
Alkermes uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@alkermes.com), used 64.2% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@alkermes.com | 64.2% |
{first initial}.{last name} | j.doe@alkermes.com | 33.7% |
About Alkermes
At Alkermes, we apply our deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. We have a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders. Our patient-inspired science, integrated research strategy, sophisticated development capabilities and specialized commercial infrastructure enable us to pursue the development and commercialization of innovative new medicines, including those for people with conditions that have traditionally been overlooked or stigmatized. Our greatest strengths at Alkermes are our people and our inherent empathy for patients, families and caregivers. Neurological and psychiatric disorders strike people at the core of who they are and impact many facets of their lives. We work with urgency to develop new treatment options for people living with these conditions. Beyond our important mission of developing medicines, we believe it is our responsibility to take a holistic approach as we seek to support patients, caregivers and broader impacted communities. We remain committed to patient engagement, responsible and sustainable operations, and equitable access to quality treatment. Headquartered in Ireland, Alkermes also has a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio. See our Community Guidelines: https://www.alkermes.com/social-community-guidelines
Alkermes revenue & valuation
| Annual revenue | $1,505,300,000 |
| Revenue per employee | $663,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $4,817,000,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 2001-5000
Seniority
Employees
Employees by Department
Alkermes has 883 employees across 19 departments.
Departments
Number of employees
Alkermes Tech Stack
Discover the technologies and tools that power Alkermes's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Webmail
Security
CMS
Analytics
Video players
UI frameworks
Analytics
Analytics
Tag managers
Miscellaneous
SSL/TLS certificate authorities
France
Japan
Canada
NetherlandsFrequently asked questions
4.8
40,000 users
